Efeitos de Momordica charantia L. em ratos diabéticos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | LOCUS Repositório Institucional da UFV |
Texto Completo: | http://locus.ufv.br/handle/123456789/2430 |
Resumo: | The objective of this study was to characterize the clinical alterations on laboratory male rats with diabetes and on healthy male rats, treated with aqueous infusion of powdered fruits of Momordica charantia L. In the biological assays, 16 male rats were induced to the experimental diabetes though intraperitoneal injection of alloxan in a dose of 75 mg/kg. The blood glucose level was verified on the sixth day after the induction and the animal with glucose superior to 180 mg/dL were distributed in two groups: Diabetic Group and Diabetic with infusion of Momordica charantia L. group (Diabetic + MC). After dividing these two groups, two others groups of healthy animals were formed: Control group and Control with infusion of Momordica charantia L. group (Control + MC). Groups with infusion of Momordica charantia L. were received a diary dose of 1 mL/250g of corporal weigh of the 10 % prepared infusion for 25 days. During the experiment were studied the following clinical parameters: weigh, hydric ingestion, alimentary ingestion, diuresis and general state. On the final of the experiment the following laboratorial dosages were realized: blood glucose level, glucagon like peptide -1 (GLP-1), cholesterol, triglycerides, alanine aminotransferase (ALT) and aspartate aminotransferase (AST). It was verified weight increase in Control an Control + MC groups with bigger percentile increase (13.89%) in the Group Control. The Diabetic group presented a 2.68% reduction and Diabetic + MC a reduction of 11.79% in the average of the weight of the animals after 25 days of experiment. The Diabetic group presented an average increase of 34.82% in the blood glucose level, being that the value remained in raised levels, above of 280 mg/dL. Diabetic + MC group presented a lesser average percentile variation for the blood glucose level, with an average increase of 27.05% in the glucose level. The results had demonstrated that the average of the blood levels of the GLP-1 in the animals of Diabetic + MC group was 32.73% greater when compared with the Diabetic group. The values of ALT was significant difference, the average of the ALT of the Control group was greater when compared with the Diabetic group, what can characterize a diabetic disease with liver alterations. However, it did not have significant difference in the ALT of the Control and Diabetic groups, when compared with the Control + MC and Diabetic + MC groups respectively, evidencing that the infusion of this plant in these experimental conditions had not modified this analyzed liver´s functions. The Control + MC group presented cholesterol reduction of 6.88% in comparison with the Control group. Diabetic and Diabetic + MC groups had not presented significant difference between its averages for cholesterol. Diabetic + MC group presented a reduction of 7.63% in the average of the values of triglycerides in relation to the Diabetic group. These results reveal that the aqueous infusion of powdered fruits of Momordica charantia was capable to increase levels of the GLP-1 and promoting a decrease of blood glucose levels of animals with diabetes. Moreover, was observed reduction of the weight profit, improves in the important clinical parameters, and no alterations in the liver´s function was observed. It is possible to conclude that the Momordica charantia L. has proper characteristics for control of the typical parameters of diabetes in these study conditions. |
id |
UFV_faf91dfeb00793e4059275698c6431ef |
---|---|
oai_identifier_str |
oai:locus.ufv.br:123456789/2430 |
network_acronym_str |
UFV |
network_name_str |
LOCUS Repositório Institucional da UFV |
repository_id_str |
2145 |
spelling |
Rocha, Marcos Túlio Alves dahttp://lattes.cnpq.br/5052522201210630Ferreira, Ronaldo Martinshttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4130981T5Pizziolo, Virgínia Ramoshttp://lattes.cnpq.br/8741147354005247Moraes, George Henrique Kling dehttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4721569T7Rodrigues, Ana Cláudia Pereshttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4794298P7Oliveira, Tânia Toledo dehttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4787758J22015-03-26T13:07:31Z2011-09-122015-03-26T13:07:31Z2010-11-26ROCHA, Marcos Túlio Alves da. Effect of Momordica charantia L. in male diabetic rats. 2010. 73 f. Dissertação (Mestrado em Bioquímica e Biologia molecular de plantas; Bioquímica e Biologia molecular animal) - Universidade Federal de Viçosa, Viçosa, 2010.http://locus.ufv.br/handle/123456789/2430The objective of this study was to characterize the clinical alterations on laboratory male rats with diabetes and on healthy male rats, treated with aqueous infusion of powdered fruits of Momordica charantia L. In the biological assays, 16 male rats were induced to the experimental diabetes though intraperitoneal injection of alloxan in a dose of 75 mg/kg. The blood glucose level was verified on the sixth day after the induction and the animal with glucose superior to 180 mg/dL were distributed in two groups: Diabetic Group and Diabetic with infusion of Momordica charantia L. group (Diabetic + MC). After dividing these two groups, two others groups of healthy animals were formed: Control group and Control with infusion of Momordica charantia L. group (Control + MC). Groups with infusion of Momordica charantia L. were received a diary dose of 1 mL/250g of corporal weigh of the 10 % prepared infusion for 25 days. During the experiment were studied the following clinical parameters: weigh, hydric ingestion, alimentary ingestion, diuresis and general state. On the final of the experiment the following laboratorial dosages were realized: blood glucose level, glucagon like peptide -1 (GLP-1), cholesterol, triglycerides, alanine aminotransferase (ALT) and aspartate aminotransferase (AST). It was verified weight increase in Control an Control + MC groups with bigger percentile increase (13.89%) in the Group Control. The Diabetic group presented a 2.68% reduction and Diabetic + MC a reduction of 11.79% in the average of the weight of the animals after 25 days of experiment. The Diabetic group presented an average increase of 34.82% in the blood glucose level, being that the value remained in raised levels, above of 280 mg/dL. Diabetic + MC group presented a lesser average percentile variation for the blood glucose level, with an average increase of 27.05% in the glucose level. The results had demonstrated that the average of the blood levels of the GLP-1 in the animals of Diabetic + MC group was 32.73% greater when compared with the Diabetic group. The values of ALT was significant difference, the average of the ALT of the Control group was greater when compared with the Diabetic group, what can characterize a diabetic disease with liver alterations. However, it did not have significant difference in the ALT of the Control and Diabetic groups, when compared with the Control + MC and Diabetic + MC groups respectively, evidencing that the infusion of this plant in these experimental conditions had not modified this analyzed liver´s functions. The Control + MC group presented cholesterol reduction of 6.88% in comparison with the Control group. Diabetic and Diabetic + MC groups had not presented significant difference between its averages for cholesterol. Diabetic + MC group presented a reduction of 7.63% in the average of the values of triglycerides in relation to the Diabetic group. These results reveal that the aqueous infusion of powdered fruits of Momordica charantia was capable to increase levels of the GLP-1 and promoting a decrease of blood glucose levels of animals with diabetes. Moreover, was observed reduction of the weight profit, improves in the important clinical parameters, and no alterations in the liver´s function was observed. It is possible to conclude that the Momordica charantia L. has proper characteristics for control of the typical parameters of diabetes in these study conditions.O objetivo deste estudo foi caracterizar as alterações clínicas e laboratoriais em ratos com diabetes e ratos sadios submetidos à infusão aquosa do pó dos frutos de Momordica charantia L. Nos ensaios biológicos, 16 ratos foram induzidos ao diabetes experimental por via intraperitoneal de aloxano na dose de 75 mg/kg. A glicemia foi verificada no sexto dia após a indução e os animais com glicemia superior a 180 mg/dL foram distribuídos em dois grupos: grupo Diabético e grupo Diabético com infusão de Momordica charantia L. (Diabético + MC). A partir de animais sadios, outros dois grupos foram formados: grupo Controle e grupo Controle com infusão de Momordica charantia L. (Controle + MC). Os grupos tratados com Momordica charantia L. receberam dose diária de um mL/250g de peso corporal da infusão preparada a 10% por um período de 25 dias. Os seguintes parâmetros clínicos foram estudados: peso, ingestão hídrica, ingestão alimentar, diurese e estado geral. Ao final do experimento, as seguintes dosagens laboratoriais foram realizadas: glicemia, polipeptídeo semelhante ao glucagon (GLP-1), triacilgliceróis, colesterol, alanina aminotransferase (ALT) e aspartato aminotransferase (AST). Verificou-se um aumento de peso nos grupos Controle e Controle + MC, com aumento percentual maior (13,89%) no Grupo Controle. O grupo Diabético apresentou uma redução de 2,68% e o Diabético + MC uma redução de 11,79% no peso após 25 dias de experimento. O grupo Diabético apresentou um aumento médio de 34,82% nos níveis glicêmicos casuais, sendo que a glicemia permaneceu em níveis elevados, acima de 280 mg/dL. O grupo Diabético + MC apresentou uma menor variação percentual média para a glicemia, com um aumento médio de 27,05% nos índices glicêmicos. Os resultados demonstraram que a média dos níveis sanguíneos do GLP-1 nos animais do Grupo Diabético + MC foi 32,73% maior quando comparado com o grupo Diabético. Observou-se que houve diferença significativa entre a média da ALT do grupo Controle comparada com a do grupo Diabético, o que pode caracterizar um quadro diabetogênico com alterações hepáticas. Contudo, não houve diferença (P>0,05) na ALT dos grupos Controle e Diabético, quando comparados com os grupos Controle + MC e Diabético + MC, respectivamente. Isso evidencia que a infusão dessa planta nessas condições experimentais não alterou as funções hepáticas analisadas. O grupo Controle + MC apresentou uma redução de colesterol de 6,88% em comparação com o grupo Controle. Os grupos Diabético e Diabético + MC não apresentaram diferença (P>0,05) entre suas médias para colesterol. O grupo Diabético + MC apresentou uma redução de 7,63% na média dos valores de triacilgliceróis em relação ao grupo Diabético. Esses resultados revelam que a ingestão da infusão aquosa dos frutos de Momordica charantia L. foi capaz de promover um aumento dos níveis sanguíneos do GLP-1 e redução dos níveis glicêmicos dos animais com diabetes. Além disso, observou-se redução do ganho de peso, melhora nos parâmetros clínicos e não alteração da função hepática. É possível concluir que o produto da Momordica charantia L. possui características próprias para controle do quadro típico do diabetes nas condições estudadas.application/pdfporUniversidade Federal de ViçosaMestrado em Bioquímica AgrícolaUFVBRBioquímica e Biologia molecular de plantas; Bioquímica e Biologia molecular animalMomordica charantia L.DiabéticoMomordica charantia L.DiabeticCNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICAEfeitos de Momordica charantia L. em ratos diabéticosEffect of Momordica charantia L. in male diabetic ratsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:LOCUS Repositório Institucional da UFVinstname:Universidade Federal de Viçosa (UFV)instacron:UFVORIGINALtexto completo.pdfapplication/pdf648770https://locus.ufv.br//bitstream/123456789/2430/1/texto%20completo.pdf19bf5bd8dcbc1671f4fcc890180123eeMD51TEXTtexto completo.pdf.txttexto completo.pdf.txtExtracted texttext/plain155983https://locus.ufv.br//bitstream/123456789/2430/2/texto%20completo.pdf.txt35d5873e29f2dbe8aceba3a9f60b572aMD52THUMBNAILtexto completo.pdf.jpgtexto completo.pdf.jpgIM Thumbnailimage/jpeg3454https://locus.ufv.br//bitstream/123456789/2430/3/texto%20completo.pdf.jpgd9af6a24349f9d150dc028014e9a1fafMD53123456789/24302016-04-08 23:03:41.783oai:locus.ufv.br:123456789/2430Repositório InstitucionalPUBhttps://www.locus.ufv.br/oai/requestfabiojreis@ufv.bropendoar:21452016-04-09T02:03:41LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)false |
dc.title.por.fl_str_mv |
Efeitos de Momordica charantia L. em ratos diabéticos |
dc.title.alternative.eng.fl_str_mv |
Effect of Momordica charantia L. in male diabetic rats |
title |
Efeitos de Momordica charantia L. em ratos diabéticos |
spellingShingle |
Efeitos de Momordica charantia L. em ratos diabéticos Rocha, Marcos Túlio Alves da Momordica charantia L. Diabético Momordica charantia L. Diabetic CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA |
title_short |
Efeitos de Momordica charantia L. em ratos diabéticos |
title_full |
Efeitos de Momordica charantia L. em ratos diabéticos |
title_fullStr |
Efeitos de Momordica charantia L. em ratos diabéticos |
title_full_unstemmed |
Efeitos de Momordica charantia L. em ratos diabéticos |
title_sort |
Efeitos de Momordica charantia L. em ratos diabéticos |
author |
Rocha, Marcos Túlio Alves da |
author_facet |
Rocha, Marcos Túlio Alves da |
author_role |
author |
dc.contributor.authorLattes.por.fl_str_mv |
http://lattes.cnpq.br/5052522201210630 |
dc.contributor.author.fl_str_mv |
Rocha, Marcos Túlio Alves da |
dc.contributor.advisor-co1.fl_str_mv |
Ferreira, Ronaldo Martins |
dc.contributor.advisor-co1Lattes.fl_str_mv |
http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4130981T5 |
dc.contributor.advisor-co2.fl_str_mv |
Pizziolo, Virgínia Ramos |
dc.contributor.advisor-co2Lattes.fl_str_mv |
http://lattes.cnpq.br/8741147354005247 |
dc.contributor.advisor1.fl_str_mv |
Moraes, George Henrique Kling de |
dc.contributor.advisor1Lattes.fl_str_mv |
http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4721569T7 |
dc.contributor.referee1.fl_str_mv |
Rodrigues, Ana Cláudia Peres |
dc.contributor.referee1Lattes.fl_str_mv |
http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4794298P7 |
dc.contributor.referee2.fl_str_mv |
Oliveira, Tânia Toledo de |
dc.contributor.referee2Lattes.fl_str_mv |
http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4787758J2 |
contributor_str_mv |
Ferreira, Ronaldo Martins Pizziolo, Virgínia Ramos Moraes, George Henrique Kling de Rodrigues, Ana Cláudia Peres Oliveira, Tânia Toledo de |
dc.subject.por.fl_str_mv |
Momordica charantia L. Diabético |
topic |
Momordica charantia L. Diabético Momordica charantia L. Diabetic CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA |
dc.subject.eng.fl_str_mv |
Momordica charantia L. Diabetic |
dc.subject.cnpq.fl_str_mv |
CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA |
description |
The objective of this study was to characterize the clinical alterations on laboratory male rats with diabetes and on healthy male rats, treated with aqueous infusion of powdered fruits of Momordica charantia L. In the biological assays, 16 male rats were induced to the experimental diabetes though intraperitoneal injection of alloxan in a dose of 75 mg/kg. The blood glucose level was verified on the sixth day after the induction and the animal with glucose superior to 180 mg/dL were distributed in two groups: Diabetic Group and Diabetic with infusion of Momordica charantia L. group (Diabetic + MC). After dividing these two groups, two others groups of healthy animals were formed: Control group and Control with infusion of Momordica charantia L. group (Control + MC). Groups with infusion of Momordica charantia L. were received a diary dose of 1 mL/250g of corporal weigh of the 10 % prepared infusion for 25 days. During the experiment were studied the following clinical parameters: weigh, hydric ingestion, alimentary ingestion, diuresis and general state. On the final of the experiment the following laboratorial dosages were realized: blood glucose level, glucagon like peptide -1 (GLP-1), cholesterol, triglycerides, alanine aminotransferase (ALT) and aspartate aminotransferase (AST). It was verified weight increase in Control an Control + MC groups with bigger percentile increase (13.89%) in the Group Control. The Diabetic group presented a 2.68% reduction and Diabetic + MC a reduction of 11.79% in the average of the weight of the animals after 25 days of experiment. The Diabetic group presented an average increase of 34.82% in the blood glucose level, being that the value remained in raised levels, above of 280 mg/dL. Diabetic + MC group presented a lesser average percentile variation for the blood glucose level, with an average increase of 27.05% in the glucose level. The results had demonstrated that the average of the blood levels of the GLP-1 in the animals of Diabetic + MC group was 32.73% greater when compared with the Diabetic group. The values of ALT was significant difference, the average of the ALT of the Control group was greater when compared with the Diabetic group, what can characterize a diabetic disease with liver alterations. However, it did not have significant difference in the ALT of the Control and Diabetic groups, when compared with the Control + MC and Diabetic + MC groups respectively, evidencing that the infusion of this plant in these experimental conditions had not modified this analyzed liver´s functions. The Control + MC group presented cholesterol reduction of 6.88% in comparison with the Control group. Diabetic and Diabetic + MC groups had not presented significant difference between its averages for cholesterol. Diabetic + MC group presented a reduction of 7.63% in the average of the values of triglycerides in relation to the Diabetic group. These results reveal that the aqueous infusion of powdered fruits of Momordica charantia was capable to increase levels of the GLP-1 and promoting a decrease of blood glucose levels of animals with diabetes. Moreover, was observed reduction of the weight profit, improves in the important clinical parameters, and no alterations in the liver´s function was observed. It is possible to conclude that the Momordica charantia L. has proper characteristics for control of the typical parameters of diabetes in these study conditions. |
publishDate |
2010 |
dc.date.issued.fl_str_mv |
2010-11-26 |
dc.date.available.fl_str_mv |
2011-09-12 2015-03-26T13:07:31Z |
dc.date.accessioned.fl_str_mv |
2015-03-26T13:07:31Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
ROCHA, Marcos Túlio Alves da. Effect of Momordica charantia L. in male diabetic rats. 2010. 73 f. Dissertação (Mestrado em Bioquímica e Biologia molecular de plantas; Bioquímica e Biologia molecular animal) - Universidade Federal de Viçosa, Viçosa, 2010. |
dc.identifier.uri.fl_str_mv |
http://locus.ufv.br/handle/123456789/2430 |
identifier_str_mv |
ROCHA, Marcos Túlio Alves da. Effect of Momordica charantia L. in male diabetic rats. 2010. 73 f. Dissertação (Mestrado em Bioquímica e Biologia molecular de plantas; Bioquímica e Biologia molecular animal) - Universidade Federal de Viçosa, Viçosa, 2010. |
url |
http://locus.ufv.br/handle/123456789/2430 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Viçosa |
dc.publisher.program.fl_str_mv |
Mestrado em Bioquímica Agrícola |
dc.publisher.initials.fl_str_mv |
UFV |
dc.publisher.country.fl_str_mv |
BR |
dc.publisher.department.fl_str_mv |
Bioquímica e Biologia molecular de plantas; Bioquímica e Biologia molecular animal |
publisher.none.fl_str_mv |
Universidade Federal de Viçosa |
dc.source.none.fl_str_mv |
reponame:LOCUS Repositório Institucional da UFV instname:Universidade Federal de Viçosa (UFV) instacron:UFV |
instname_str |
Universidade Federal de Viçosa (UFV) |
instacron_str |
UFV |
institution |
UFV |
reponame_str |
LOCUS Repositório Institucional da UFV |
collection |
LOCUS Repositório Institucional da UFV |
bitstream.url.fl_str_mv |
https://locus.ufv.br//bitstream/123456789/2430/1/texto%20completo.pdf https://locus.ufv.br//bitstream/123456789/2430/2/texto%20completo.pdf.txt https://locus.ufv.br//bitstream/123456789/2430/3/texto%20completo.pdf.jpg |
bitstream.checksum.fl_str_mv |
19bf5bd8dcbc1671f4fcc890180123ee 35d5873e29f2dbe8aceba3a9f60b572a d9af6a24349f9d150dc028014e9a1faf |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV) |
repository.mail.fl_str_mv |
fabiojreis@ufv.br |
_version_ |
1801212998998556672 |